Inject Solesta: For durable efficacy up to 36 months^1,2

• 30% increased of Responder₅₀rate from month 3 to month 12¹

• All three studies show durability of the treatment effect to 24 months as evidenced by proportion Responder₅₀²

• The pivotal study, the only study followed to 36 months, showed durability of treatment effect to 36 months^1,2

• Responder₅₀ defined as proportion of patients with 50% reduction in the number of incontinence episodes compared to baseline, has been used to objectively evaluate response to treatments for FI in other studies²

Learn more about greater control with Solesta